Next Generation Diagnostic System (NGDS) Operational Test and Evaluation Report
Abstract
This report provides the Director, Operational Test and Evaluation (DOT and E) evaluation of the Next Generation Diagnostic System (NGDS) in support of a Full-Rate Production decision. This is an update to the June 2017 Early Fielding Report in which DOT and E assessed the NGDS to be operationally effective and suitable in providing land-based deployable medical units with timely clinical sample analysis to support the diagnosis and treatment of symptomaticpatients.1Based on testing conducted since June 2017, the NGDS is also operationally effective for use aboard Navy ships and for the analysis of environmental samples to confirm the presence of biological warfare agents (BWAs). Analytical laboratories equipped with the NGDS are able to prepare and analyze environmental samples to provide timely and accurate information to support commanders situational awareness and make force protection decisions. The NGDS meets the user requirement for sensitivity in aerosol samples and most of the other sample types used in testing. 2 The system demonstrated a false identification rate of 1 percent in operationally realistic samples. NGDS provides a measurable improvement in capability over the Joint Biological Agent Diagnostic System (JBAIDS) that it replaces.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2018
- Accession Number
- AD1169336
Entities
People
- Robert F. Behler
Organizations
- Office of the Secretary of Defense